North Okaloosa Dialysis Center is a medicare approved dialysis facility center in Crestview, Florida and it has 15 dialysis stations. It is located in Okaloosa county at 320 W Redstone Ave, Crestview, FL, 32536. You can reach out to the office of North Okaloosa Dialysis Center at (850) 683-5700. This dialysis clinic is managed and/or owned by Davita. North Okaloosa Dialysis Center has the following ownership type - Profit. It was first certified by medicare in July, 1999. The medicare id for this facility is 102759 and it accepts patients under medicare ESRD program.
| Name | North Okaloosa Dialysis Center |
|---|---|
| Location | 320 W Redstone Ave, Crestview, Florida |
| No. of Dialysis Stations | 15 |
| Medicare ID | 102759 |
| Managed By | Davita |
| Ownership Type | Profit |
| Late Shifts | No |
| 320 W Redstone Ave, Crestview, Florida, 32536 | |
| (850) 683-5700 | |
News Archive
Chicago plastic surgeon Gregory A. Turowski, MD, PhD, FACS, has been invited to be part of Harvard Medical School's "I Am Harvard," sharing his outcomes in the field of plastic surgery and advances in robotic hair restoration.
The discovery of the UM171 molecule, by Dr. Guy Sauvageau and Anne Marinier, made headlines in 2014 following an article in Science. Hailed by some as a revolution, even a miracle, in the field of blood stem cell transplantation, the UM171 molecule is delivering on its promise.
Researchers at Memorial Sloan-Kettering Cancer Center, together with collaborators in Germany, have developed a new method for identifying the cell of origin of intracellular and secreted proteins within multicellular environments.
BESLER Consulting, a leading financial and operational consultancy to healthcare providers, is pleased to announce the expansion of their Care Coordination and Compliance practice, with the integration of Dr. Frank L. Urbano's expertise and experience.
› Verified 4 days ago
| NPI Number | 1629046362 |
| Organization Name | North Okaloosa Dialysis |
| Doing Business As | Renal Treatment Centers Southeast Lp |
| Address | 320 Redstone Ave W Crestview, Florida, 32536 |
| Phone Number | (850) 683-5700 |
News Archive
Chicago plastic surgeon Gregory A. Turowski, MD, PhD, FACS, has been invited to be part of Harvard Medical School's "I Am Harvard," sharing his outcomes in the field of plastic surgery and advances in robotic hair restoration.
The discovery of the UM171 molecule, by Dr. Guy Sauvageau and Anne Marinier, made headlines in 2014 following an article in Science. Hailed by some as a revolution, even a miracle, in the field of blood stem cell transplantation, the UM171 molecule is delivering on its promise.
Researchers at Memorial Sloan-Kettering Cancer Center, together with collaborators in Germany, have developed a new method for identifying the cell of origin of intracellular and secreted proteins within multicellular environments.
BESLER Consulting, a leading financial and operational consultancy to healthcare providers, is pleased to announce the expansion of their Care Coordination and Compliance practice, with the integration of Dr. Frank L. Urbano's expertise and experience.
› Verified 4 days ago
| Dialysis patients with Hemoglobin data | 22 |
| Medicare patients who had average hemoglobin (hgb) less than 10 g/dL | 9 |
News Archive
Chicago plastic surgeon Gregory A. Turowski, MD, PhD, FACS, has been invited to be part of Harvard Medical School's "I Am Harvard," sharing his outcomes in the field of plastic surgery and advances in robotic hair restoration.
The discovery of the UM171 molecule, by Dr. Guy Sauvageau and Anne Marinier, made headlines in 2014 following an article in Science. Hailed by some as a revolution, even a miracle, in the field of blood stem cell transplantation, the UM171 molecule is delivering on its promise.
Researchers at Memorial Sloan-Kettering Cancer Center, together with collaborators in Germany, have developed a new method for identifying the cell of origin of intracellular and secreted proteins within multicellular environments.
BESLER Consulting, a leading financial and operational consultancy to healthcare providers, is pleased to announce the expansion of their Care Coordination and Compliance practice, with the integration of Dr. Frank L. Urbano's expertise and experience.
› Verified 4 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
| Adult patients getting regular hemodialysis at the center | 33 |
| Adult patient months included in Kt/V greater than or equal to 1.2 | 302 |
| Percentage of adult patients getting regular hemodialysis at the center | 97 |
| Percentage of pediatric patients getting regular hemodialysis at the center |
News Archive
Chicago plastic surgeon Gregory A. Turowski, MD, PhD, FACS, has been invited to be part of Harvard Medical School's "I Am Harvard," sharing his outcomes in the field of plastic surgery and advances in robotic hair restoration.
The discovery of the UM171 molecule, by Dr. Guy Sauvageau and Anne Marinier, made headlines in 2014 following an article in Science. Hailed by some as a revolution, even a miracle, in the field of blood stem cell transplantation, the UM171 molecule is delivering on its promise.
Researchers at Memorial Sloan-Kettering Cancer Center, together with collaborators in Germany, have developed a new method for identifying the cell of origin of intracellular and secreted proteins within multicellular environments.
BESLER Consulting, a leading financial and operational consultancy to healthcare providers, is pleased to announce the expansion of their Care Coordination and Compliance practice, with the integration of Dr. Frank L. Urbano's expertise and experience.
› Verified 4 days ago
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at North Okaloosa Dialysis Center with elevated calcium levels.
| Patients with hypercalcemia | 33 |
| Hypercalcemia patient months | 302 |
| Patients with Serumphosphor | 33 |
| Patients with Serumphosphor less than 3.5 mg/dL | 11 |
| Patients with Serumphosphor from 3.5 to 4.5 mg/dL | 34 |
| Patients with Serumphosphor from 4.6 to 5.5 mg/dL | 34 |
| Patients with Serumphosphor from 5.6 to 7 mg/dL | 14 |
| Patients with Serumphosphor greater than 7 mg/dL | 7 |
News Archive
Chicago plastic surgeon Gregory A. Turowski, MD, PhD, FACS, has been invited to be part of Harvard Medical School's "I Am Harvard," sharing his outcomes in the field of plastic surgery and advances in robotic hair restoration.
The discovery of the UM171 molecule, by Dr. Guy Sauvageau and Anne Marinier, made headlines in 2014 following an article in Science. Hailed by some as a revolution, even a miracle, in the field of blood stem cell transplantation, the UM171 molecule is delivering on its promise.
Researchers at Memorial Sloan-Kettering Cancer Center, together with collaborators in Germany, have developed a new method for identifying the cell of origin of intracellular and secreted proteins within multicellular environments.
BESLER Consulting, a leading financial and operational consultancy to healthcare providers, is pleased to announce the expansion of their Care Coordination and Compliance practice, with the integration of Dr. Frank L. Urbano's expertise and experience.
› Verified 4 days ago
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
| Patients included in arterial venous fistula and catheter summaries | 51 |
| Patient months included in arterial venous fistula and catheter summaries | 305 |
| Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | 65 |
| Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer | 5 |
News Archive
Chicago plastic surgeon Gregory A. Turowski, MD, PhD, FACS, has been invited to be part of Harvard Medical School's "I Am Harvard," sharing his outcomes in the field of plastic surgery and advances in robotic hair restoration.
The discovery of the UM171 molecule, by Dr. Guy Sauvageau and Anne Marinier, made headlines in 2014 following an article in Science. Hailed by some as a revolution, even a miracle, in the field of blood stem cell transplantation, the UM171 molecule is delivering on its promise.
Researchers at Memorial Sloan-Kettering Cancer Center, together with collaborators in Germany, have developed a new method for identifying the cell of origin of intracellular and secreted proteins within multicellular environments.
BESLER Consulting, a leading financial and operational consultancy to healthcare providers, is pleased to announce the expansion of their Care Coordination and Compliance practice, with the integration of Dr. Frank L. Urbano's expertise and experience.
› Verified 4 days ago
The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.
| Standard Hospitalization Summary Ratio(SHR) Year | January, 2016 - December, 2016 |
| Patients in facility's Hospitalization Summary | 32 |
| Hospitalization Rate in facility | 151.6 (As Expected) |
| Hospitalization Rate: Upper Confidence Limit | 311.6 |
| Hospitalization Rate: Lower Confidence Limit | 78.1 |
News Archive
Chicago plastic surgeon Gregory A. Turowski, MD, PhD, FACS, has been invited to be part of Harvard Medical School's "I Am Harvard," sharing his outcomes in the field of plastic surgery and advances in robotic hair restoration.
The discovery of the UM171 molecule, by Dr. Guy Sauvageau and Anne Marinier, made headlines in 2014 following an article in Science. Hailed by some as a revolution, even a miracle, in the field of blood stem cell transplantation, the UM171 molecule is delivering on its promise.
Researchers at Memorial Sloan-Kettering Cancer Center, together with collaborators in Germany, have developed a new method for identifying the cell of origin of intracellular and secreted proteins within multicellular environments.
BESLER Consulting, a leading financial and operational consultancy to healthcare providers, is pleased to announce the expansion of their Care Coordination and Compliance practice, with the integration of Dr. Frank L. Urbano's expertise and experience.
› Verified 4 days ago
The rate of readmission show you whether patients who were being treated regularly at North Okaloosa Dialysis Center were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.
| Standard Readmission Summary Ratio(SRR) Year | January, 2016 - December, 2016 |
| Readmission Rate in facility | 27.6 (As Expected) |
| Readmission Rate: Upper Confidence Limit | 45 |
| Readmission Rate: Lower Confidence Limit | 14.8 |
News Archive
Chicago plastic surgeon Gregory A. Turowski, MD, PhD, FACS, has been invited to be part of Harvard Medical School's "I Am Harvard," sharing his outcomes in the field of plastic surgery and advances in robotic hair restoration.
The discovery of the UM171 molecule, by Dr. Guy Sauvageau and Anne Marinier, made headlines in 2014 following an article in Science. Hailed by some as a revolution, even a miracle, in the field of blood stem cell transplantation, the UM171 molecule is delivering on its promise.
Researchers at Memorial Sloan-Kettering Cancer Center, together with collaborators in Germany, have developed a new method for identifying the cell of origin of intracellular and secreted proteins within multicellular environments.
BESLER Consulting, a leading financial and operational consultancy to healthcare providers, is pleased to announce the expansion of their Care Coordination and Compliance practice, with the integration of Dr. Frank L. Urbano's expertise and experience.
› Verified 4 days ago
Hemodialysis treatment requires direct access to the bloodstream, which can be an opportunity for germs to enter the body and cause infection. This information shows how often patients at North Okaloosa Dialysis Center get infections in their blood each year compared to the number of infections expected for the center based on the national average.
| Standard Infection Summary Ratio(SIR) Year | January, 2016 - December, 2016 |
| Infection Rate in facility | 1.42 (As Expected) |
| SIR: Upper Confidence Limit | 4.7 |
| SIR: Lower Confidence Limit | .24 |
News Archive
Chicago plastic surgeon Gregory A. Turowski, MD, PhD, FACS, has been invited to be part of Harvard Medical School's "I Am Harvard," sharing his outcomes in the field of plastic surgery and advances in robotic hair restoration.
The discovery of the UM171 molecule, by Dr. Guy Sauvageau and Anne Marinier, made headlines in 2014 following an article in Science. Hailed by some as a revolution, even a miracle, in the field of blood stem cell transplantation, the UM171 molecule is delivering on its promise.
Researchers at Memorial Sloan-Kettering Cancer Center, together with collaborators in Germany, have developed a new method for identifying the cell of origin of intracellular and secreted proteins within multicellular environments.
BESLER Consulting, a leading financial and operational consultancy to healthcare providers, is pleased to announce the expansion of their Care Coordination and Compliance practice, with the integration of Dr. Frank L. Urbano's expertise and experience.
› Verified 4 days ago
Patients with anemia require blood transfusions if their anemia is not managed well by their dialysis center. This information shows whether North Okaloosa Dialysis Center's rate of transfusions is better than expected, as expected, or worse than expected, compared to other centers that treat similar patients.
| Standard Transfusion Summary Ratio (STrR) Year | January, 2016 - December, 2016 |
| Patients in facility's Transfusion Summary | 31 |
| Transfusion Rate in facility | 9.3 (As Expected) |
| Transfusion Rate: Upper Confidence Limit | 113.4 |
| Transfusion Rate: Lower Confidence Limit | 1 |
News Archive
Chicago plastic surgeon Gregory A. Turowski, MD, PhD, FACS, has been invited to be part of Harvard Medical School's "I Am Harvard," sharing his outcomes in the field of plastic surgery and advances in robotic hair restoration.
The discovery of the UM171 molecule, by Dr. Guy Sauvageau and Anne Marinier, made headlines in 2014 following an article in Science. Hailed by some as a revolution, even a miracle, in the field of blood stem cell transplantation, the UM171 molecule is delivering on its promise.
Researchers at Memorial Sloan-Kettering Cancer Center, together with collaborators in Germany, have developed a new method for identifying the cell of origin of intracellular and secreted proteins within multicellular environments.
BESLER Consulting, a leading financial and operational consultancy to healthcare providers, is pleased to announce the expansion of their Care Coordination and Compliance practice, with the integration of Dr. Frank L. Urbano's expertise and experience.
› Verified 4 days ago
The rate of mortality show you whether patients who were being treated regularly at North Okaloosa Dialysis Center lived longer than expected (better than expected), don’t live as long as expected (worse than expected), or lived as long as expected (as expected), compared to similar patients treated at other facilities.
| Standard Survival Summary Ratio(SIR) Year | January, 2013 - December, 2016 |
| Patients in facility's Survival Summary | 116 |
| Mortality Rate in facility | 12.6 (As Expected) |
| Mortality Rate: Upper Confidence Limit | 22.1 |
| Mortality Rate: Lower Confidence Limit | 6.5 |
News Archive
Chicago plastic surgeon Gregory A. Turowski, MD, PhD, FACS, has been invited to be part of Harvard Medical School's "I Am Harvard," sharing his outcomes in the field of plastic surgery and advances in robotic hair restoration.
The discovery of the UM171 molecule, by Dr. Guy Sauvageau and Anne Marinier, made headlines in 2014 following an article in Science. Hailed by some as a revolution, even a miracle, in the field of blood stem cell transplantation, the UM171 molecule is delivering on its promise.
Researchers at Memorial Sloan-Kettering Cancer Center, together with collaborators in Germany, have developed a new method for identifying the cell of origin of intracellular and secreted proteins within multicellular environments.
BESLER Consulting, a leading financial and operational consultancy to healthcare providers, is pleased to announce the expansion of their Care Coordination and Compliance practice, with the integration of Dr. Frank L. Urbano's expertise and experience.
› Verified 4 days ago
Nephrology Center Of Crestview Location: 129 Redstone Ave, Crestview, Florida, 32539 Phone: (850) 682-4726 |
North Okaloosa Dialysis Center Location: 320 W Redstone Ave, Crestview, Florida, 32536 Phone: (850) 683-5700 |
News Archive
Chicago plastic surgeon Gregory A. Turowski, MD, PhD, FACS, has been invited to be part of Harvard Medical School's "I Am Harvard," sharing his outcomes in the field of plastic surgery and advances in robotic hair restoration.
The discovery of the UM171 molecule, by Dr. Guy Sauvageau and Anne Marinier, made headlines in 2014 following an article in Science. Hailed by some as a revolution, even a miracle, in the field of blood stem cell transplantation, the UM171 molecule is delivering on its promise.
Researchers at Memorial Sloan-Kettering Cancer Center, together with collaborators in Germany, have developed a new method for identifying the cell of origin of intracellular and secreted proteins within multicellular environments.
BESLER Consulting, a leading financial and operational consultancy to healthcare providers, is pleased to announce the expansion of their Care Coordination and Compliance practice, with the integration of Dr. Frank L. Urbano's expertise and experience.
› Verified 4 days ago